BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 850918)

  • 1. The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States.
    Opelz G; Terasaki P; Myers L; Ellison G; Ebers G; Zabriskie J; Weiner H; Kempe H; Sibley W
    Tissue Antigens; 1977 Jan; 9(1):54-8. PubMed ID: 850918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis.
    Bertrams HJ; Kuwert EK
    J Immunol; 1976 Nov; 117(5 Pt.2):1906-12. PubMed ID: 993587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens in multiple sclerosis.
    Thorsby E; Helgesen A; Solheim BG; Vandvik B
    J Neurol Sci; 1977 Jun; 32(2):187-93. PubMed ID: 301557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
    Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
    Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA in multiple sclerosis. Relationship to measles antibody, mitogen responsiveness and clinical course.
    Paty DW; Dossetor JB; Stiller CR; Cousin HK; Marchuk L; Furesz J; Boucher DW
    J Neurol Sci; 1977 Jul; 32(3):371-9. PubMed ID: 886362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-D typing in multiple sclerosis: Israelis tested with European homozygous typing cells.
    Brautbar C; Amar A; Cohen N; Oksenberg J; Cohen I; Kahana E; Bloch D; Alter M; Grosse-Wilde H
    Tissue Antigens; 1982 Mar; 19(3):189-97. PubMed ID: 6953617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigens and mitogen responsiveness in multiple sclerosis.
    Paty DW; Cousin HK; Stiller CR
    Transplant Proc; 1977 Mar; 9(1 Suppl 1):187-9. PubMed ID: 300927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA and Japanese MS.
    Naito S; Kuroiwa Y; Itoyama T; Tsubaki T; Horikawa A; Sasazuki T; Noguchi S; Ohtsuki S; Tokuomi H; Miyatake T; Takahata N; Kawanami S
    Tissue Antigens; 1978 Jul; 12(1):19-24. PubMed ID: 80838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.
    Poskanzer DC; Terasaki PI; Prenney LB; Sheridan JL; Park MS
    J Epidemiol Community Health; 1980 Dec; 34(4):253-7. PubMed ID: 6972433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
    Madigand M; Fauchet R; Oger J; Sabouraud O
    Nouv Presse Med; 1981 Jun; 10(28):2349-52. PubMed ID: 7267340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigen segregation analysis in multiple sclerosis (MS) families.
    Bertrams J; Kuwert E
    Z Immunitatsforsch Immunobiol; 1976 Nov; 152(3):200-8. PubMed ID: 1007375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA antigens and antibody responses to measles and rubella viruses in multiple sclerosis.
    Ilonen J; Herva E; Reunanen M; Panelius M; Meurman O; Arstila P; Tiilikainen A
    Acta Neurol Scand; 1977 Apr; 55(4):299-309. PubMed ID: 855642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong linkage disequilibrium between HLA-Dw2 and and BfS in multiple sclerosis and in the normal population.
    Stewart GJ; Basten A; Kirk RL
    Tissue Antigens; 1979 Aug; 14(2):86-97. PubMed ID: 91230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histocompatibility determinants in Israeli Jewish patients with multiple sclerosis.
    Brautbar C; Cohen I; Kahana E; Alter M; Jorgensen F; Lamm L
    Tissue Antigens; 1977 Oct; 10(4):291-302. PubMed ID: 72427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DW2, viral immunity and family studies in multiple sclerosis.
    Stewart GJ; Basten A; Guinan J; Bashir HV; Cameron J; McLeod JG
    J Neurol Sci; 1977 Jun; 32(2):153-67. PubMed ID: 874517
    [No Abstract]   [Full Text] [Related]  

  • 16. Histocompatibility antigens (HLA) in multiple sclerosis in Iran.
    Lotfi J; Nikbin B; Derakhshan I; Aghai Z; Ala F
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):699-701. PubMed ID: 681957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of HLA antigens in multiple sclerosis.
    Jersild C
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):516-30. PubMed ID: 415750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Multiple sclerosis susceptibility and histocompatibility determinants.
    Alter M; Harshe M; Yunis EJ
    Neurology; 1975 May; 25(5):489. PubMed ID: 1169709
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA-D typing with an association of Dw2 and absent immune responses towards herpes simplex (type i) antigen in multiple sclerosis.
    Paty DW; Cousin HK; Stiller CR; Boucher DW; Furesz J; Warren KG; Marchuk L; Dossetor JB
    Transplant Proc; 1977 Dec; 9(4):1845-8. PubMed ID: 203060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.